Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
Biochemical and Biophysical Research Communications, 06/16/09
Matsui T et al. - The authors present study provides a unique beneficial aspect of nifedipine on diabetic nephropathy; it could work as an anti-inflammatory agent against AGE by suppressing RAGE expression in cultured mesangial cells via PPAR-gamma activation.
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09
Does Diabetes Mellitus Predispose to Increased Fluid Overload in Peritoneal Dialysis Patients
Nephron: Clinical Practice, 10/12/09
Parathyroid hormone measurement in CKD
Kidney International, 10/08/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Interventions for HIV-associated nephropathy
Cochrane Reviews, 10/19/09
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09
Acute phosphate nephropathy
Current Opinion in Nephrology and Hypertension, 10/15/09
Article Search
Sponsor


See Latest Articles


